Pharvaris expects pivotal HAE study data in third quarter 2026

Go back to Pharvaris expects pivotal HAE study data in third quarter 2026
(NASDAQ: PHVS) Delayed: 31.54 +0.13 (0.41%)
Previous Close $31.41    52 Week High $ 
Open $31.38    52 Week Low $ 
Day High $32.08    P/E N/A 
Day Low $31.30    EPS $ 
Volume 347,675